(Q34069720)

30 July 2017

title

CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy (English)

1 reference

Correction for de Nigris et al., CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy

30 July 2017

1 reference

corrigendum / erratum

0 references

Hermes J Garban

6

0 references

Antonio Barbieri

Antonio Barbieri

16

0 references

Mario Petrillo

Mario Petrillo

14

0 references

Alfonso Giovane

Alfonso Giovane

3

0 references

Filomena de Nigris

Filomena de Nigris

1

0 references

Francesca Pentimalli

Francesca Pentimalli

8

0 references

Antonella Petrillo

Antonella Petrillo

10

0 references

Claudio Arra

Claudio Arra

17

0 references

Franco Rengo

Franco Rengo

18

0 references

Claudio Napoli

Claudio Napoli

22

0 references

Antonio Giordano

Antonio Giordano

5

0 references

Louis Ignarro

21

Louis J Ignarro

1 reference

30 July 2017

4

Amelia Casamassimi

1 reference

30 July 2017

11

Letizia Cito

1 reference

30 July 2017

Valeria Crudele

2

1 reference

30 July 2017

Francesco Cacciatore

7

1 reference

30 July 2017

Diana C Marquez-Garban

9

1 reference

30 July 2017

Linda Sommese

12

1 reference

30 July 2017

Andrea Fiore

13

1 reference

30 July 2017

Alfredo Siani

15

1 reference

30 July 2017

Toshio Hayashi

19

1 reference

30 July 2017

Mohammed Al-Omran

20

1 reference

30 July 2017

language of work or name

English

0 references

publication date

26 July 2010

1 reference

Proceedings of the National Academy of Sciences of the United States of America

30 July 2017

published in

1 reference

30 July 2017

volume

107

1 reference

30 July 2017

issue

32

1 reference

30 July 2017

page(s)

14484-14489

1 reference

Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922579

Regulation of the transcription factor YY1 in mitosis through phosphorylation of its DNA-binding domain

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922579

Targeting angiogenesis: progress with anti-VEGF treatment with large molecules

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922579

Adverse effects of anticancer agents that target the VEGF pathway

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922579

A critical analysis of current in vitro and in vivo angiogenesis assays

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922579

PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922579

Translating an Antagonist of Chemokine Receptor CXCR4: from bench to bedside

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922579

VEGF-A splicing: the key to anti-angiogenic therapeutics?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922579

Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922579

VEGF-targeted therapy: mechanisms of anti-tumour activity.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922579

New insights on the role of CXCR4 in cancer metastasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922579

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922579

Inhibition of Yin Yang 1-dependent repressor activity of DR5 transcription and expression by the novel proteasome inhibitor NPI-0052 contributes to its TRAIL-enhanced apoptosis in cancer cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922579

Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4/angiogenesis and metastasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922579

CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922579

Novel challenges in exploring peptide ligands and corresponding tissue-specific endothelial receptors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922579

Expression of transcription factor Yin Yang 1 in human osteosarcomas

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922579

Transcription factor YY1: structure, function, and therapeutic implications in cancer biology.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922579

Yin Yang 1 is a negative regulator of p53.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922579

The biology of VEGF and its receptors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922579

Tumorigenesis and the angiogenic switch

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922579

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2922579

Nitric oxide inhibits the transcription repressor Yin-Yang 1 binding activity at the silencer region of the Fas promoter: a pivotal role for nitric oxide in the up-regulation of Fas gene expression in human tumor cells

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.1008256107

A phase 1 study of mapatumumab (fully human monoclonal antibody to TRAIL-R1) in patients with advanced solid malignancies.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.1008256107

Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.1008256107

Characterization of the transcriptional regulator YY1. The bipartite transactivation domain is independent of interaction with the TATA box-binding protein, transcription factor IIB, TAFII55, or cAMP-responsive element-binding protein (CPB)-binding

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20660740

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1073/PNAS.1008256107

1 reference

30 July 2017

0 references

1 reference

30 July 2017

1 reference